CV team being moved to Respiratory launch

Discussion in 'Amgen' started by anonymous, Oct 12, 2020 at 1:34 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Amgen is looking to buy more respiratory assets and be a leader now that GSK is stepping down from respiratory. Amgen to merge with AZ. McKinsey has been hired for dilligence.
     

  2. anonymous

    anonymous Guest

    McKinsey was also working with Enron.
     
  3. anonymous

    anonymous Guest

    So are we throwing in the towel on Repatha?
     
  4. anonymous

    anonymous Guest

    New pipeline priority in oncology and new business areas. Respiratory will be a priority if TSLP ends up being a hit and Amgen wants new and better assets in this area.
     
  5. anonymous

    anonymous Guest

    Kate Tansey will fuck this up
     
  6. anonymous

    anonymous Guest

    Amgen CLPs = overrated
     
  7. anonymous

    anonymous Guest

    Eric Jensen was Rolf's dirty right hand man.
     
  8. anonymous

    anonymous Guest

    CLP is wasted program at Amgen. Talent is all smoke and mirrors. They are paying for high GMAT scores and that's it
     
  9. anonymous

    anonymous Guest

    I agree these CLPs are overrated talents and most are pretty shitty. Top mba my ass.
     
  10. anonymous

    anonymous Guest

    After Amgen buys Acceleron to give reps two products to launch with TSLP
     
  11. anonymous

    anonymous Guest

    Acceleron Chief Commercial Officer Sujay Kango " Make me rich twice bitches!"
     
  12. anonymous

    anonymous Guest

    This didnt age well at all bhahaha